Neurocrine Biosciences (NBIX) Intangibles (2022 - 2025)

Neurocrine Biosciences has reported Intangibles for 4 years, with the latest figure at $35.7 million in Q3 2025.

• For the quarter ending Q3 2025, Intangibles rose 3.48% year-over-year to $35.7 million; the trailing twelve-month figure through Sep 2025 stood at $35.7 million (up 3.48% YoY), and the FY2024 full-year result was $36.5 million, up 2.82% from the prior year.
• Intangibles for Q3 2025 stood at $35.7 million, down from $37.2 million in the prior quarter.
• The five-year high for Intangibles was $37.2 million in Q4 2022, with the low at $33.5 million in Q2 2024.
• Historically, Intangibles has averaged $35.8 million across 4 years, with a median of $36.0 million in 2025.
• Annual changes were most pronounced in 2024 — Intangibles retreated 9.21% — and 2025, when it gained 11.04%.
• Neurocrine Biosciences' Intangibles stood at $37.2 million in 2022, then retreated by 4.57% to $35.5 million in 2023, then gained by 2.82% to $36.5 million in 2024, then dropped by 2.19% to $35.7 million in 2025.
• The last three Intangibles figures came in at $35.7 million (Q3 2025), $37.2 million (Q2 2025), and $36.4 million (Q1 2025), per Business Quant data.